Industry News
Medical Device Industry News
BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
CE Marking and ARCH clinical trial data position the Liverty™ TIPS Stent Graft to expand treatment options for patients with advanced liver disease The post BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care
Finding Common Regulatory Ground in AIs Growing Role within Pharmacovigilance | By: Anuradha (Annie) Prabhakar, Associate Director, Product Management, Vigilance Detect, IQVIA
Pharmacovigilance has traditionally required organizations to balance the urgency of reporting with the rigor of accurately detecting adverse event and product complaints. AI has the potential to ease this burden by enabling earlier pre‑signal identification,
Variational AI Releases Enki 4: Major Update to Foundation Model for Small-Molecule Drug Discovery
Variational AI introduces Enki™ 4: an improved algorithm and architecture designed to scale, expanding the pre-trained target coverage from 592 to 760 and now applicable to proximity-based therapeutics and novel payloads for antibody drug conjugates
The Frontline of Patient Care: Rethinking Medical Clinic Waiting Room Safety
Equipping these frontline workers with comprehensive first aid and CPR in Ottawa ensures that every clinic operates with a seamless, highly prepared safety protocol from the very moment a patient walks through the front door.
Bailey & Galyen Signs Multi-Million Dollar Deal as Choctaw Stadium’s Exclusive Legal Sponsor
The new partnership builds on a relationship between Bailey & Galyen in Mansfield TX and the Texas Rangers since 2022, when the firm first became the club's official legal sponsor. The post Bailey & Galyen
Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention
Mechanism-Driven Study Design Focused on Capital Efficiency and Accelerated Development for Near-Term Value Creation, Addressing a $2 Billion Potential Target Market The post Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
Akira Kitamura, GM, AI Drug Development Division of NEC Corporation and CEO of NEC Bio, added, "This agreement is an important milestone in our partnership with Transgene and reflects NEC’s long-term commitment to the development
Managing Co-Occurring Mental Health and Substance Use Disorders
Dealing with both mental health issues and substance use disorders in tandem can feel overwhelming. Many individuals find that symptoms from one disorder often aggravate the other, complicating not only their daily lives but also
Who Should NOT Use Online Prescriptions?
Many people are turning to online prescriptions because they are fast and easy. You can talk to a doctor, get advice, and receive medication without leaving home. Platforms like RoenRx make this process simple. But
Ellipsys Vascular Access System to Return to U.S. Market in 2026
Ellipsys Medical, Inc. today announced that the Ellipsys® Vascular Access System will once again be commercially available, with initial availability anticipated in mid-2026. The announcement marks the planned reintroduction of the minimally invasive technology to
SynerFuse® Announces VP of Strategy: Thomas T. Lee, M.D., FAANS, MBA
Dr. Lee is a renowned talent, in the fields of both neurosurgery and finance The post SynerFuse® Announces VP of Strategy: Thomas T. Lee, M.D., FAANS, MBA first appeared on Medical Device News Magazine.
Metacarpal Adds Certified Prosthetist to Strengthen North American Expansion
In her role with Metacarpal, Richer will focus on clinical education and support, helping prosthetists, therapists, and care teams understand where the Metacarpal GEM can fit within care pathways and how to optimize outcomes for
Genesys Spine Announces Launch of the SIros-X™ System for Sacroiliac Joint Fusion and Pelvic Fixation of Pedicle Screw Constructs
Inaugural case performed by spine surgeon Dr. Scott L. Parker highlights the system's strength, versatility, and precision for supporting multi-level spinal constructs The post Genesys Spine Announces Launch of the SIros-X™ System for Sacroiliac Joint
Restore Robotics Receives FDA 510(k) Clearance for 2 Additional da Vinci Xi® Robotic Instruments
With these latest clearances, Restore Robotics continues to deliver on its mission to provide hospitals and surgery centers with cost-effective, high-quality, and sustainable alternatives to purchasing new robotic instruments from original equipment manufacturers. The post
AIROS Medical Appoints Dr John Evans as Lead Medical Advisor
Dr John Evans is a well-respected and renowned physician, educator, and speaker, and we are ecstatic to have him join our medical team," said Gerald Malkoid, CEO of AIROS Medical. The post AIROS Medical Appoints
The Powerful Value of Eating Fresh Organic Vegetables
In a world where convenience often wins out over quality, fresh, organic vegetables offer a refreshing return to food that nourishes both the body and the planet. They’re more than a trend; they represent a
Why CPR Training Should Be Part of Every Family’s Health Plan
When families think about staying healthy, the focus is often on regular checkups, balanced meals, exercise, and vaccinations. While these are all essential, there is one critical component that is often overlooked: being prepared for
Cartessa Aesthetics and Classys Introduce QUADESSY, a Faster, Safer and More Versatile Microneedling Radiofrequency Platform
Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design The post Cartessa Aesthetics and Classys Introduce QUADESSY, a Faster, Safer and More Versatile Microneedling Radiofrequency Platform first appeared on Medical Device News
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care The post Philips launches IntraSight Plus to simplify coronary interventions and
Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study for Geographic Atrophy Secondary to AMD
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD The post Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study